Even though various physiological conditions and pathophysiological processes such as obesity (11), anxiety (12), food intake (13), chronic pain (14), neurodegenerative disorders (15), and bone disease (2) have been proven to require NPY to participate, its effect on bone metabolism is still poorly understood. This evidence concerns the gene NPY and obesity due to melanocortin 4 receptor deficiency.